This compromised refractoriness of Ca 2þ release, in turn, permits the RyR2 channels to reopen during diastole, causing DCR to activate depolarizing membrane currents, resulting in pro-arrhythmic delayed afterdepolarizations (10, (13) (14) (15) . Independent of the underlying etiology, compromised RyR2 function is a hallmark of catecholaminergic polymorphic ventricular tachycardia (CPVT).
Episodes of cardiac arrhythmias in CPVT patients
are precipitated by emotional stress or exercise, which are associated with increased levels of circulating catecholamines (2, 11, 16) . In accordance with the clinical presentation of a vast majority of these arrhythmias, b-blocker therapy is the mainstay of treatment for cardiac rhythm disorders (17) (26) . These channels were initially described in neurons (hence their eponym) and are characterized by a high sensitivity to tetrodotoxin (TTX) (24, (27) (28) (29) and all data was normalized to glyceraldehyde 3-phosphate dehydrogenase.
Radwa nski et al. intraperitoneal injection of epinephrine (1.5 mg/kg) and caffeine (120 mg/kg; red ECGs). A subset of mice was pre-treated with Ril (15 mg/kg; purple ECGs). Arrhythmia and ventricular tachycardia (VT) incidence (%) in CPVT mice exposed to catecholamine challenge during Na þ -channel blockade with riluzole (n ¼ 13 vs. n ¼ 18 CPVT-EpiþCaff vs.
CPVT-EpiþCaff-Ril treated mice. *p ¼ 0.043 and *p ¼ 0.023 Fisher exact test for arrhythmia and VT incidence, respectively).
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Radwa nski et al. Confocal micrographs of PLA signal were low pass filtered (Gaussian) and thresholded to generate a black and white mask of the whole myocyte. This was used to calculate myocyte area. The unfiltered image was then thresholded using Otsu's method, followed by nearest-neighbor cluster detection to segment the PLA punctae. The punctae within the whole cell mask areas were counted to determine the density of PLA punctae within the cell (per mm Recently, Na þ channel inhibitors flecainide and riluzole emerged as effective therapies in CPVT models (23, 26) . Interestingly, riluzole (10 mmol/l, Sigma) and flecainide (2.5 mmol/l, Sigma) both also reduced DCR frequency ( Figure 1A , purple and blue traces and bars). Notably, consistent with previous reports
Radwa nski et al. Figure 4A) and significantly more arrhythmic DCR events relative to ISO-naive CPVT myocytes ( Figures 1A and 2B ). (1 mmol/l, Sigma) prevented ISO-induced persistent
Radwa nski et al. Figure 4A ). To more precisely examine the localization of these channels with respect to RyR2 in CPVT, we performed a PLA (37) . We found that all Na þ channel isoforms were closely colocalized (within <40 nm [37] ) with RyR2 ( Figure 4B) ; however, Na v 1. Wilcoxon rank sum test). Abbreviations as in Figure 1 .
Radwa nski et al. Radwa nski et al. To test this, first we conducted a dose response experiment with m-conotoxin SmIIIA, which can discriminate between TTX-sensitive Na þ channel isoforms (45) . Specifically, at very low nmol/l concentrations, m-conotoxin SmIIIA inhibits Na v 1.1 and Na v 1.3 (45) . Despite the putative inhibition of Na v 1.1
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and Na v 1.3, 50 nmol/l m-conotoxin SmIIIA (Cusabio, Wuhan, China) did not significantly alter ISO-induced persistent I Na in CPVT myocytes ( Figure 5 ). However, a concentration of m-conotoxin SmIIIA near the IC 50 for Na v 1.6 (100 nmol/l) (45) partially reduced ISO-induced persistent I Na , whereas 300 nmol/l m-conotoxin SmIIIA virtually abolished this ISO-induced phenomenon ( Figure 5 ). These data suggest that Na v 1.6 can potentially contribute to the ISO-induced persistent I Na and arrhythmias in CPVT.
To examine this possibility further in both cardiac myocytes and in vivo we used a selective Na v 1.6 inhibitor, 4,9-anhydro-TTX (Focus Biomolecules) (46, 47) . Notably, ISO-induced persistent I Na in CPVT cardiomyocytes was sensitive to 300 nmol/l 4,9-anhydro-TTX ( Figure 6A ), suggesting that this ISO-promoted persistent I Na is for the most part carried by Na v 1.6.
Furthermore, the addition of 300 nmol/l 4,9-anhydro-TTX to CPVT myocytes reduced the frequency of ISO-promoted DCRs ( Figure 6B) . Similarly, pre-treatment of CPVT mice with 4,9-anhydro-TTX (750 mg/kg) markedly reduced VT vulnerability during catecholamine challenge ( Figure 6C , blue ECG and bar). Notably, this intervention had no significant effect on SR Ca 2þ load (Supplemental Figure 6 ).
We further addressed the role of Na v 1.6 in CPVT by an siRNA approach to selectively target Na v 1.6 (Supplemental Figure 7) . CPVT mice injected with siRNA against Na v 1.6 showed a marked decrease in arrhythmia episodes during catecholamine challenge regulates RyR2 gating (7) (8) (9) 11, 12, 15) . Therefore, CPVTassociated mutations in CASQ2 impair the ability of Our structural and functional studies make a very compelling case for the involvement of nNa v in the arrhythmogenic process. However, this does not preclude the cardiac isoform of the Na þ channels (Na v 1.5) from contributing to arrhythmogenesis. In fact, early reports have described late I Na as a component of the cardiac I Na that can be inhibited by ranolazine (54) . This late I Na was presumably carried by Na v 1.5 and is a reflection of cell-wide sarcolemmal Na v 1.5 activity. Here, we show that Na v 1.5 is present despite having similar effect on persistent I Na , more profoundly affected peak I Na relative to 100 nmol/l TTX (Supplemental Figure 3) , a concentration that completely blocks nNa v although mostly sparing Na v 1.5 (24, (27) (28) (29) . These data would further suggest that because 10 mmol/l riluzole inhibits both peak and persistent I Na to a similar extent as 100 nmol/l TTX, it may perhaps elicit its DCR-stabilizing effect through blockade of nNa v . However, future studies will need to determine the specific Na 
